Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Swimming Bio-Bots Designed to Traverse Biologic Aquatic Environments

By BiotechDaily International staff writers
Posted on 27 Jan 2014
Print article
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Scientists have devised synthetic, tiny self-propelled swimming bio-bots that are able to move through the aquatic fluids of the body.

A team of engineers has developed a type of tiny bio-hybrid machines that swim similar to sperm, the first synthetic structures that can traverse the viscous fluids of biologic environments by themselves. A report on the study led by Taher Saif, a University of Illinois (I of U; Urbana-Champaign, USA) professor of mechanical science and engineering, was published on January 18, 2014, in the journal Nature Communications. “Microorganisms have a whole world that we only glimpse through the microscope,” Prof. Saif said. “This is the first time that an engineered system has reached this underworld.”

The engineers started by creating the body of the bio-bot from a flexible polymer. Then they cultured heart cells near the junction of the head and the tail. The cells self-align and synchronize to beat together, sending a wave down the tail that pushes the bio-bot forward.

This self-organization is an amazing new phenomenon, according to Prof. Saif; however, how the cells talk with each other on the flexible polymer tail is yet to be effectively determined. However, the cells need to beat together, in the right direction, for the tail to move. “It’s the minimal amount of engineering—just a head and a wire,” Prof. Saif said. “Then the cells come in, interact with the structure, and make it functional.”

The researchers also constructed two-tailed bots, which they found could swim even faster. Multiple tails also creates new avenues of navigation. The researchers foresee future bots that could sense or light or chemicals and move toward a target for medical or environmental applications. “The long-term vision is simple,” said Prof. Saif, who is also from the Beckman Institute for Advanced Science and Technology at the U of I. “Could we make elementary structures and seed them with stem cells that would differentiate into smart structures to deliver drugs, perform minimally invasive surgery or target cancer?”

The swimming bio-bot project is part of a larger US National Science Foundation-supported Science and Technology Center on Emergent Behaviors in Integrated Cellular Systems, which also produced the walking bio-bots developed at Illinois in 2012.

“The most intriguing aspect of this work is that it demonstrates the capability to use computational modeling in conjunction with biological design to optimize performance, or design entirely different types of swimming bio-bots,” said center director Dr. Roger Kamm, a professor of biological and mechanical engineering at the Massachusetts Institute of Technology (MIT; Cambridge MA, USA). “This opens the field up to a tremendous diversity of possibilities--truly an exciting advance.”

Related Links:

University of Illinois



Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.